✨ Your Portfolio is fetched and updated from zerodha.
Micro Chemicals

Infinium Pharmachem Ltd.

INFINIUM

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹425 Cr.
P/E
52.17

Infinium Pharmachem Ltd.

  • Infinium Pharmachem
  • Bhatia Colour Chem
  • Mangalam Organics
FAQs on Infinium Pharmachem Ltd. Shareprice

Infinium Pharmachem has given better returns compared to its competitors.
Infinium Pharmachem has grown at ~41.48% over the last 1yrs while peers have grown at a median rate of -32.52%

Infinium Pharmachem is expensive when considering the PE ratio, however latest EV/EBIDTA is < 3 yr avg EV/EBIDTA.
Latest PE of Infinium Pharmachem is 52.17, while 3 year average PE is 36.28.
Also latest EV/EBITDA of Infinium Pharmachem is 15.81 while 3yr average is 16.06.

View FAQ's On Business
Growth Table
  • Infinium Pharmachem Ltd.
  • Bhatia Colour Chem
  • Mangalam Organics
Balance Sheet
  • Infinium Pharmachem Ltd.
  • Bhatia Colour Chem
  • Mangalam Organics
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Infinium Pharmachem Ltd.
  • Bhatia Colour Chem
  • Mangalam Organics
Cash Flow
  • Infinium Pharmachem Ltd.
  • Bhatia Colour Chem
  • Mangalam Organics
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Infinium Pharmachem Ltd.
  • Bhatia Colour Chem
  • Mangalam Organics
Quarterly Results
  • Infinium Pharmachem Ltd.
  • Bhatia Colour Chem
  • Mangalam Organics
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF
FAQs on Infinium Pharmachem Ltd. Financials

Balance sheet of Infinium Pharmachem is strong.
It shouldn't have solvency or liquidity issues.

The net debt of Infinium Pharmachem is decreasing.
Latest net debt of Infinium Pharmachem is -₹34.84 Crs as of Mar-25.
This is less than Mar-24 when it was -₹11.92 Crs.

The profit is oscillating.
The profit of Infinium Pharmachem is ₹7.84 Crs for TTM, ₹11.3 Crs for Mar 2024 and ₹9.49 Crs for Mar 2023.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Infinium Pharmachem latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly unproductive assets like Cash & Short Term Investments, Inventory, Accounts Receivable

View FAQ's On Shareholding
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech